Table III.
Analysis of trial counts and fractions in the 20 cancers with highest UK mortality
| Mortality |
Interventional trials |
Biological trials |
mAb trials |
|||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| All conditions | N/A | N/A | 78510 | 82.5 | 7049 | 9.0 | 1536 | 2.0 |
| All non-cancer conditions | N/A | N/A | 56208 | 80.7 | 3396 | 6.0 | 503 | 0.9 |
| All cancers | 156 723 | 100 | 22 302 | 87.4 | 3653 | 16.4 | 1033 | 4.6 |
| Lung | 35 261 | 22.5 | 2373 | 10.6 | 294 | 8.0 | 91 | 8.8 |
| Colorectal | 16 259 | 10.4 | 1558 | 7.0 | 234 | 6.4 | 100 | 9.7 |
| Breast | 12 116 | 7.7 | 2932 | 13.1 | 442 | 12.1 | 130 | 12.6 |
| Prostate | 10 168 | 6.5 | 1506 | 6.8 | 188 | 5.1 | 34 | 3.3 |
| Pancreas | 7781 | 5.0 | 782 | 3.5 | 141 | 3.9 | 31 | 3.0 |
| Oesophagus | 7606 | 4.9 | 448 | 2.0 | 61 | 1.7 | 11 | 1.1 |
| Stomach | 5178 | 3.3 | 530 | 2.4 | 53 | 1.5 | 10 | 1.0 |
| Bladder | 5002 | 3.2 | 322 | 1.4 | 61 | 1.7 | 4 | 0.4 |
| Non-Hodgkin lymphoma | 4438 | 2.8 | 1825 | 8.2 | 575 | 15.7 | 204 | 19.7 |
| Ovary | 4373 | 2.8 | 1124 | 5.0 | 220 | 6.0 | 43 | 4.2 |
| All leukaemias | 4367 | 2.8 | 2584 | 11.6 | 663 | 18.1 | 163 | 15.8 |
| Kidney | 3848 | 2.5 | 827 | 3.7 | 233 | 6.4 | 36 | 3.5 |
| Brain and CNS | 3674 | 2.3 | 1105 | 5.0 | 157 | 4.3 | 41 | 4.0 |
| Liver | 3390 | 2.2 | 803 | 3.6 | 101 | 2.8 | 26 | 2.5 |
| Multiple myeloma | 2660 | 1.7 | 1116 | 5.0 | 260 | 7.1 | 31 | 3.0 |
| Mesothelioma | 2156 | 1.4 | 143 | 0.6 | 18 | 0.5 | 8 | 0.8 |
| Malignant melanoma | 2067 | 1.3 | 851 | 3.8 | 366 | 10.0 | 46 | 4.5 |
| Oral | 1822 | 1.2 | 1298 | 5.8 | 121 | 3.3 | 18 | 1.7 |
| Uterus | 1741 | 1.1 | 678 | 3.0 | 98 | 2.7 | 8 | 0.8 |
| Bone and connective tissue | 1037 | 0.7 | 1832 | 8.2 | 432 | 11.8 | 58 | 5.6 |